Psychedelic microdosing benefits and challenges: an empirical codebook
Harm Reduction Journal – July 09, 2019
Source: OpenAlex
Summary
Microdosing reports from a vast community reveal promising avenues for future scientific inquiry. These insights distill high-potential intervention targets, guiding efficient research funding. Focusing on substances like Psilocybin and Lysergic acid diethylamide, popular hallucinogens, this work bridges Psychology and Pharmacology. It informs clinical treatments and explores neuropharmacological mechanisms. Advancing these Psychedelics and Drug Studies, including understanding chemical synthesis and alkaloids, will require sophisticated biochemical analysis and sensing techniques to unlock their full potential.
Abstract
These mixed-methods results help summarize and frame the experiences reported by an active microdosing community as high-potential avenues for future scientific research. The MDBC taxonomy reported here informs future research, leveraging participant reports to distil the highest-potential intervention targets so research funding can be efficiently allocated. Microdosing research complements the full-dose literature as clinical treatments are developed and neuropharmacological mechanisms are sought. This framework aims to inform researchers and clinicians as experimental microdosing research begins in earnest in the years to come.